Fighting drug resistance with tailored combinations of antibiotics that kill microbes in different ways

January 11, 2017
Fighting drug resistance with tailored combinations of antibiotics that kill microbes in different ways
Using colistin in combination with other antibiotics (rifampicin, tigecycline and meropenem) proved more effective in treating multidrug-resistant bacteria than applying the antibiotics individually. That is because the four antibiotics used had different killing mechanisms against microbes. Credit: Ref 1. Copyright (2016), with permission from Elsevier.

Triple-pronged attacks on microbes that cause life-threatening lung infections are much more effective than individual antibiotics, A*STAR researchers have found. Using cocktails of antibiotics is promising for addressing the rising menace of multidrug-resistant microbes.

Multidrug-resistant bacteria are the plague of the twenty-first century and are predicted to become the leading cause of death by 2050, surpassing even cancer and diabetes, says Desmond Heng Wen Chien of the A*STAR Institute of Chemical and Engineering Sciences. "It is imperative that we act now to stem the rise of antimicrobial resistance and to mitigate its impact with more robust, but safer therapies," he urges.

In particular, superbugs that cause respiratory are posing an increasingly ominous threat. They have dire clinical outcomes, with mortality rates reaching as high as 80 per cent for some infections. Furthermore, they have begun to spread from hospitals to the community at large. The last line of defense against such superbugs is the highly toxic antibiotic known as colistin, but there are recent reports of infections that are resistant to even that.

Now, Heng and his co-workers have shown that using three tailored combinations of colistin with two other antibiotics can effectively combat lung infections caused by multidrug-resistant superbugs. They found that all three formulations were highly effective against the multidrug-resistance pathogens in the laboratory. In concocting these combinations, the team drew on initial laboratory screening data and existing clinical data to obtain more effective and robust formulations.

Since the four antibiotics used in these cocktails employ different mechanisms to kill bacteria (see image), their ternary combinations exhibit significant synergistic and additive effects. Their combined effectiveness is much greater than their individual application. The triple-killing mechanism of these ternary combinations, and the potential to rotate the three combinations during therapy, makes it much harder for microbes to develop resistance to them. Using other antibiotics in combination with colistin has the added advantage that it reduces the amount of colistin needed and the toxicity to the patient.

The are easy to self-administer. "Our formulations are designed to be delivered into the deep-lung region by a portable, easy-to-use dry-powder inhaler, which is faster, more direct and more convenient than other modes of treatment," says Heng.

The team intends to conduct in vivo studies in animals and then humans in collaboration with hospital clinicians. The researchers note that the same strategy could be applied to fight other drug-resistant bacteria.

Explore further: Research on new, rapid screening test identifies potential therapies against drug-resistant bacteria

More information: Sie Huey Lee et al. Tailored Antibiotic Combination Powders for Inhaled Rotational Antibiotic Therapy, Journal of Pharmaceutical Sciences (2016). DOI: 10.1016/j.xphs.2016.02.007

Related Stories

Q&A: Superbug precursor found in US again

July 11, 2016

A New York City patient was infected with bacteria that had a special type of resistance to antibiotics last year, the earliest known case in the U.S. of bacteria that could lead to a superbug impervious to medications.

Recommended for you

Preliminary study suggests possible new treatment for MS

April 20, 2017

A small, preliminary study may show promise of a new type of treatment for progressive multiple sclerosis (MS). Results from the first six people enrolled in the phase 1 study, a study designed to enroll 10 people, are being ...

A promising target for kidney fibrosis

April 20, 2017

When the kidneys - vital organs for filtering the body's entire blood supply - become injured, it can set in motion an unfortunate chain of events that leads to a decline in health. Sometimes, in response to chronic injury, ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.